Comparison of Efficacy, Safety, and Tolerability of Neoral vs Sandimmun in De Novo Renal Transplant Patients Over 24 Months' Treatment

By Abendroth D.   Buchholz B.   Land W.   May G.   Wiesel M.   Farber L.   Korn A.   Maibucher A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 275-276

Elsevier

Access to resources Recommend Favorite

Sandimmun and neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant

By De Palma M.T.   Giordano M.   Colella V.   Palumbo F.   De Nicolo V.E.   Caringella D.A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1677-1677

Elsevier

Access to resources Recommend Favorite

The Swedish Nationwide Experience of Converting Transplant Patients Treated With Sandimmun to the New Galenic Formulation Sandimmun-Neoral

By Swedish Sandimmun-Neoral Conversion Group   Wilczek H.E.   Berglin E.   Blohme I.   Backman L.   Fehrman I.   Kallen R.   Nyberg G.   Sawe J.   Wahlberg J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 280-283

Elsevier

Access to resources Recommend Favorite

Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patients

By Djeffal R.   Hiesse C.   Kriaa F.   Hafi A.   Boubenider S.   Ammor M.   Durrbach A.   Von Ey F.   Droupy S.   Hammoudi Y.   Eschwege P.   Benot G.   Charpentier B.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2765-2766

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Cyclosporine A Profiles Under Long-Term Neoral Treatment in Renal Transplant Recipients: Does Fat Intake Still Matter?

By Klauser R.M.   Irschik H.   Kletzmayr J.   Sturm I.   Brunner W.   Woloszczuk W.   Kovarik J.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 3137-3140

Elsevier

Access to resources Recommend Favorite